“…Interrater reliability (IRR) for CHR‐P ascertainment has also been excellent, both for the SIPS (median kappa across 16 published samples 0.89) (Woods et al, 2019) and the CAARMS (median across three studies 0.845) (Fusar‐Poli et al, 2012; Miyakoshi et al, 2009; Paterlini et al, 2019). IRR for attenuated positive symptoms has also been excellent for both SIPS (median ICC across 21 published samples 0.88) (Woods et al, 2019) and CAARMS (median ICC or Pearson r across eight studies 0.89) (Braham et al, 2014; Fusar‐Poli et al, 2012; Lho et al, 2021; Miyakoshi et al, 2009; Paterlini et al, 2019; Wang et al, 2022; Yokusoglu et al, 2021; Yung et al, 2005).…”